A Middle East respiratory syndrome coronavirus (MERS CoV) vaccine candidate was shown to be safe, well-tolerated, and induced a robust immune response in a Phase 1 first-in-human clinical trial. Initial findings from the ...
Jul 25, 2019
0
2
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine's safety and tolerability as well as its ability to induce an immune response in healthy volunteers. Scientists at the ...
Apr 03, 2019
0
1
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus has been designed in an international research effort. RSV is second only to malaria as a cause of infant mortality worldwide. The new vaccine ...
Mar 07, 2019
0
80
Vaccines that induce protective T-cell responses could protect against members across the filovirus family, according to a study published February 28 in the open-access journal PLOS Pathogens by Tomáš Hanke of the University ...
Feb 28, 2019
0
0
There is more positive news to report about the Ebola subunit vaccine candidate developed by University of Hawaiʻi at Mānoa scientist Axel Lehrer. The potential vaccine remains viable in extreme heat conditions for several ...
Feb 25, 2019
0
2
Looking back, Otto remembers struggling to breathe when he was as young as four. Exertion would make him cough, and the coughing fits would go on and on. Growing up in a family of eight children in a village in northern Uganda, ...
Feb 12, 2019
0
4
Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate. The trial is being conducted at the Saint Louis University ...
Jan 23, 2019
0
1
The first research showing that VSV-ZEBOV vaccine could help protect against Ebola brought sighs of relief. It was an incredible and humbling achievement that had only been possible due to the global collaboration of researchers, ...
Dec 07, 2018
0
1
Researchers at the University of Hawaii medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and monkeys from the infection.
Dec 04, 2018
0
96
The Walter Reed Army Institute of Research (WRAIR) this week administered the first vaccine in a Phase 1 clinical trial to evaluate the safety and immunogenicity of a Marburg vaccine candidate in healthy adult volunteers.
Oct 15, 2018
0
27
